Company / Assets per Share
Candel Therapeutics, Inc. Assets per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.42
FY2023
5-year range
$1.42 / $7.67
FY2021-FY2023
Trend
-47.4%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $7.67 to $1.42 over the past 2 years.
Based on SEC 10-K filings.
1.42 in FY2023.
Declined from $7.67 to $1.42 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, assets per share decreased 47.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $1.42 | -47.4% |
| FY2022 | $2.71 | -64.7% |
| FY2021 | $7.67 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026